Trade Cue Health Inc. - HLTH CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.0085 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026235% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.004012% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Cue Health Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Prev. Close* | 0.3374 |
Open* | 0.3328 |
1-Year Change* | -89.4% |
Day's Range* | 0.29 - 0.3328 |
52 wk Range | 0.27-3.49 |
Average Volume (10 days) | 497.75K |
Average Volume (3 months) | 8.35M |
Market Cap | 45.45M |
P/E Ratio | -100.00K |
Shares Outstanding | 154.63M |
Revenue | 251.03M |
EPS | -1.83 |
Dividend (Yield %) | N/A |
Beta | -100.00K |
Next Earnings Date | Mar 13, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Dec 1, 2023 | 0.3087 | -0.0275 | -8.18% | 0.3362 | 0.3362 | 0.2899 |
Nov 30, 2023 | 0.3374 | 0.0153 | 4.75% | 0.3221 | 0.3399 | 0.3193 |
Nov 29, 2023 | 0.3147 | 0.0173 | 5.82% | 0.2974 | 0.3147 | 0.2974 |
Nov 28, 2023 | 0.3000 | 0.0141 | 4.93% | 0.2859 | 0.3002 | 0.2859 |
Nov 27, 2023 | 0.2843 | -0.0256 | -8.26% | 0.3099 | 0.3150 | 0.2843 |
Nov 24, 2023 | 0.3007 | -0.0149 | -4.72% | 0.3156 | 0.3156 | 0.2925 |
Nov 22, 2023 | 0.2998 | 0.0029 | 0.98% | 0.2969 | 0.3059 | 0.2949 |
Nov 21, 2023 | 0.2938 | -0.0328 | -10.04% | 0.3266 | 0.3266 | 0.2869 |
Nov 20, 2023 | 0.3189 | -0.0201 | -5.93% | 0.3390 | 0.3390 | 0.3130 |
Nov 17, 2023 | 0.3300 | 0.0100 | 3.13% | 0.3200 | 0.3400 | 0.3200 |
Nov 16, 2023 | 0.3200 | 0.0200 | 6.67% | 0.3000 | 0.3300 | 0.2900 |
Nov 15, 2023 | 0.3000 | 0.0000 | 0.00% | 0.3000 | 0.3200 | 0.2600 |
Nov 14, 2023 | 0.3100 | 0.0000 | 0.00% | 0.3100 | 0.3200 | 0.3000 |
Nov 13, 2023 | 0.3200 | 0.0100 | 3.23% | 0.3100 | 0.3200 | 0.3000 |
Nov 10, 2023 | 0.3100 | 0.0000 | 0.00% | 0.3100 | 0.3100 | 0.2900 |
Nov 9, 2023 | 0.3100 | -0.0200 | -6.06% | 0.3300 | 0.3300 | 0.3000 |
Nov 8, 2023 | 0.3100 | 0.0100 | 3.33% | 0.3000 | 0.3100 | 0.3000 |
Nov 7, 2023 | 0.3200 | 0.0000 | 0.00% | 0.3200 | 0.3200 | 0.3200 |
Oct 27, 2023 | 0.2900 | 0.0000 | 0.00% | 0.2900 | 0.2900 | 0.2900 |
Oct 26, 2023 | 0.3200 | -0.0200 | -5.88% | 0.3400 | 0.3400 | 0.3200 |
Cue Health Inc. Events
Time (UTC) | Country | Event |
---|---|---|
Wednesday, March 13, 2024 | ||
Time (UTC) 10:59 | Country US
| Event Q4 2023 Cue Health Inc Earnings Release Q4 2023 Cue Health Inc Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
Total revenue | 483.476 | 618.107 | 22.953 | 6.626 |
Revenue | 483.476 | 618.107 | 22.953 | 6.626 |
Cost of Revenue, Total | 329.973 | 276.542 | 14.951 | 0 |
Gross Profit | 153.503 | 341.565 | 8.002 | 6.626 |
Total Operating Expense | 689.128 | 429.886 | 68.689 | 27.393 |
Selling/General/Admin. Expenses, Total | 185.683 | 108.517 | 24.65 | 5.988 |
Research & Development | 171.452 | 42.829 | 28.478 | 21.405 |
Operating Income | -205.652 | 188.221 | -45.736 | -20.767 |
Interest Income (Expense), Net Non-Operating | -0.645 | -69.369 | -0.374 | -0.152 |
Other, Net | 2.493 | 0.325 | -1.242 | 0.313 |
Net Income Before Taxes | -203.804 | 119.177 | -47.352 | -20.606 |
Net Income After Taxes | -194.056 | 86.418 | -47.352 | -20.606 |
Net Income Before Extra. Items | -194.056 | 86.418 | -47.352 | -20.606 |
Net Income | -194.056 | 86.418 | -47.352 | -20.606 |
Income Available to Common Excl. Extra. Items | -194.056 | 86.418 | -47.352 | -20.606 |
Income Available to Common Incl. Extra. Items | -194.056 | 86.418 | -47.352 | -20.606 |
Diluted Net Income | -194.056 | 86.418 | -47.352 | -20.606 |
Diluted Weighted Average Shares | 148.025 | 146.629 | 143.767 | 143.767 |
Diluted EPS Excluding Extraordinary Items | -1.31097 | 0.58936 | -0.32937 | -0.14333 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | ||
Diluted Normalized EPS | -1.3021 | 0.59925 | -0.32512 | -0.14333 |
Unusual Expense (Income) | 2.02 | 1.998 | 0.61 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 9.896 | 24.765 | 146.777 | 69.589 | 87.7 |
Revenue | 9.896 | 24.765 | 146.777 | 69.589 | 87.7 |
Cost of Revenue, Total | 29.346 | 39.823 | 90.783 | 50.595 | 101.898 |
Gross Profit | -19.45 | -15.058 | 55.994 | 18.994 | -14.198 |
Total Operating Expense | 95.289 | 120.615 | 185.401 | 137.002 | 190.163 |
Selling/General/Admin. Expenses, Total | 22.762 | 28.186 | 38.469 | 43.754 | 42.382 |
Research & Development | 36.536 | 44.733 | 56.149 | 42.516 | 44 |
Unusual Expense (Income) | 6.645 | 7.873 | 0 | 0.137 | 1.883 |
Operating Income | -85.393 | -95.85 | -38.624 | -67.413 | -102.463 |
Interest Income (Expense), Net Non-Operating | -0.291 | -0.22 | -0.232 | -0.346 | -0.016 |
Other, Net | 1.82 | 1.872 | 2.035 | 0.409 | 0.043 |
Net Income Before Taxes | -83.864 | -94.198 | -36.821 | -67.35 | -102.436 |
Net Income After Taxes | -83.864 | -94.198 | -31.506 | -66.303 | -99.05 |
Net Income Before Extra. Items | -83.864 | -94.198 | -31.506 | -66.303 | -99.05 |
Net Income | -83.864 | -94.198 | -31.506 | -66.303 | -99.05 |
Income Available to Common Excl. Extra. Items | -83.864 | -94.198 | -31.506 | -66.303 | -99.05 |
Income Available to Common Incl. Extra. Items | -83.864 | -94.198 | -31.506 | -66.303 | -99.05 |
Diluted Net Income | -83.864 | -94.198 | -31.506 | -66.303 | -99.05 |
Diluted Weighted Average Shares | 151.869 | 151.084 | 149.769 | 148.286 | 147.498 |
Diluted EPS Excluding Extraordinary Items | -0.55221 | -0.62348 | -0.21036 | -0.44713 | -0.67153 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -0.50846 | -0.57137 | -0.21036 | -0.44653 | -0.66324 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
Total Current Assets | 371.153 | 670.022 | 183.698 | 15.504 |
Cash and Short Term Investments | 241.53 | 409.873 | 121.578 | 14.328 |
Cash & Equivalents | 241.53 | 409.873 | 121.578 | 14.328 |
Total Receivables, Net | 18.751 | 104.589 | 4.168 | 0.2 |
Accounts Receivable - Trade, Net | 18.751 | 104.589 | 4.168 | 0.2 |
Total Inventory | 82.21 | 88.388 | 36.842 | 0 |
Prepaid Expenses | 15.728 | 45.889 | 13.847 | 0.669 |
Other Current Assets, Total | 12.934 | 21.283 | 7.263 | 0.307 |
Total Assets | 694.58 | 940.06 | 316.328 | 27.361 |
Property/Plant/Equipment, Total - Net | 274.596 | 256.93 | 111.964 | 11.63 |
Property/Plant/Equipment, Total - Gross | 357.551 | 298.599 | 122.186 | 19.532 |
Accumulated Depreciation, Total | -82.955 | -41.669 | -10.222 | -7.902 |
Intangibles, Net | 16.867 | 7.673 | 2.038 | 0 |
Other Long Term Assets, Total | 31.964 | 5.435 | 18.628 | 0.227 |
Total Current Liabilities | 71.195 | 166.936 | 155.896 | 4.751 |
Accounts Payable | 7.15 | 37.208 | 23.847 | 1.168 |
Accrued Expenses | 60.117 | 36.645 | 9.619 | 0.566 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 2.362 | 2.621 | 6.683 | 2.977 |
Other Current Liabilities, Total | 1.566 | 90.462 | 115.747 | 0.04 |
Total Liabilities | 118.086 | 233.31 | 241.405 | 11.795 |
Total Long Term Debt | 0.849 | 3.271 | 3.188 | 4.315 |
Long Term Debt | 0 | 1.331 | 3.818 | |
Capital Lease Obligations | 0.849 | 3.271 | 1.857 | 0.497 |
Other Liabilities, Total | 46.042 | 63.103 | 82.321 | 2.729 |
Total Equity | 576.494 | 706.75 | 74.923 | 15.566 |
Redeemable Preferred Stock | 0 | 176.323 | 73.705 | |
Common Stock | 0.001 | 0.001 | 0 | 0 |
Additional Paid-In Capital | 794.567 | 730.767 | 9.036 | 4.945 |
Retained Earnings (Accumulated Deficit) | -218.074 | -24.018 | -110.436 | -63.084 |
Total Liabilities & Shareholders’ Equity | 694.58 | 940.06 | 316.328 | 27.361 |
Total Common Shares Outstanding | 150.406 | 146.403 | 143.767 | 143.767 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total Current Assets | 212.075 | 286.997 | 371.153 | 521.872 | 620.135 |
Cash and Short Term Investments | 128.551 | 178.201 | 241.53 | 304.654 | 363.124 |
Cash & Equivalents | 128.551 | 178.201 | 241.53 | 304.654 | 363.124 |
Total Receivables, Net | 1.707 | 9.799 | 18.751 | 24.779 | 54.008 |
Accounts Receivable - Trade, Net | 1.707 | 9.799 | 18.751 | 24.779 | 54.008 |
Total Inventory | 68.373 | 82.006 | 82.21 | 133.309 | 139.047 |
Prepaid Expenses | 9.318 | 11.617 | 15.728 | 44.355 | 50.436 |
Other Current Assets, Total | 4.126 | 5.374 | 12.934 | 14.775 | 13.52 |
Total Assets | 523.859 | 608.561 | 694.58 | 825.036 | 914.075 |
Property/Plant/Equipment, Total - Net | 258.199 | 268.739 | 274.596 | 279.543 | 276.102 |
Property/Plant/Equipment, Total - Gross | 362.316 | 362.252 | 357.551 | 351.866 | 337.997 |
Accumulated Depreciation, Total | -104.117 | -93.513 | -82.955 | -72.323 | -61.895 |
Intangibles, Net | 21.769 | 19.774 | 16.867 | 16.044 | 10.936 |
Other Long Term Assets, Total | 31.816 | 33.051 | 31.964 | 7.577 | 6.902 |
Total Current Liabilities | 57.03 | 67.458 | 71.195 | 175.462 | 210.031 |
Accounts Payable | 11.21 | 16.644 | 7.15 | 32.521 | 38.351 |
Accrued Expenses | 43.596 | 47.912 | 60.117 | 55.461 | 83.499 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 1.756 | 2.148 | 2.362 | 2.581 | 2.605 |
Other Current Liabilities, Total | 0.468 | 0.754 | 1.566 | 84.899 | 85.576 |
Total Liabilities | 100.682 | 112.698 | 118.086 | 235.076 | 273.702 |
Total Long Term Debt | 0 | 0.417 | 0.849 | 1.268 | 1.99 |
Long Term Debt | |||||
Capital Lease Obligations | 0 | 0.417 | 0.849 | 1.268 | 1.99 |
Other Liabilities, Total | 43.652 | 44.823 | 46.042 | 58.346 | 61.681 |
Total Equity | 423.177 | 495.863 | 576.494 | 589.96 | 640.373 |
Redeemable Preferred Stock | |||||
Common Stock | 0.002 | 0.002 | 0.001 | 0.001 | 0.001 |
Additional Paid-In Capital | 819.311 | 808.133 | 794.567 | 776.527 | 760.637 |
Retained Earnings (Accumulated Deficit) | -396.136 | -312.272 | -218.074 | -186.568 | -120.265 |
Total Liabilities & Shareholders’ Equity | 523.859 | 608.561 | 694.58 | 825.036 | 914.075 |
Total Common Shares Outstanding | 152.662 | 151.568 | 150.406 | 149.178 | 147.834 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
Net income/Starting Line | -194.056 | 86.418 | -47.352 | -20.606 |
Cash From Operating Activities | -111.919 | -9.449 | 92.655 | -12.996 |
Cash From Operating Activities | 44.942 | 32.509 | 6.282 | 3.653 |
Non-Cash Items | 71.192 | 120.142 | 5.646 | 0.338 |
Cash Interest Paid | 0 | 0.767 | -0.113 | 0.045 |
Changes in Working Capital | -30.529 | -251.986 | 128.079 | 3.619 |
Cash From Investing Activities | -63.031 | -115.717 | -78.148 | -2.945 |
Capital Expenditures | -63.031 | -115.717 | -78.148 | -2.945 |
Cash From Financing Activities | -6.43 | 419.621 | 100.243 | 3.61 |
Financing Cash Flow Items | 0.635 | -8.128 | -3.564 | 0 |
Issuance (Retirement) of Stock, Net | -4.216 | 201.968 | 101.079 | 0.012 |
Issuance (Retirement) of Debt, Net | -2.849 | 225.781 | 2.728 | 3.598 |
Net Change in Cash | -181.38 | 294.455 | 114.75 | -12.331 |
Cash Taxes Paid | 3.789 | 18.106 | 0.34 | |
Deferred Taxes | -3.468 | 3.468 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -94.198 | -194.056 | -162.55 | -96.247 | 2.803 |
Cash From Operating Activities | -53.883 | -111.919 | -60.219 | -20.311 | 31.521 |
Cash From Operating Activities | 12.064 | 44.942 | 32.989 | 21.585 | 10.606 |
Non-Cash Items | 17.1 | 71.192 | 100.503 | 79.863 | 18.096 |
Cash Interest Paid | 0 | 0 | 0 | 0.023 | 0 |
Changes in Working Capital | 11.151 | -30.529 | -27.683 | -23.298 | 0.016 |
Cash From Investing Activities | -8.318 | -63.031 | -52.946 | -34.68 | -14.055 |
Capital Expenditures | -8.318 | -63.031 | -52.946 | -34.68 | -14.055 |
Cash From Financing Activities | -1.128 | -6.43 | -4.557 | -4.261 | -0.873 |
Financing Cash Flow Items | 0.37 | 0.635 | 0.378 | 0.086 | 0.273 |
Issuance (Retirement) of Stock, Net | -0.828 | -4.216 | -2.755 | -2.956 | -0.45 |
Issuance (Retirement) of Debt, Net | -0.67 | -2.849 | -2.18 | -1.391 | -0.696 |
Net Change in Cash | -63.329 | -181.38 | -117.722 | -59.252 | 16.593 |
Deferred Taxes | -3.468 | -3.478 | -2.214 | ||
Cash Taxes Paid | 0 | 3.789 | 0 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
Tarsadia Capital, LLC | Investment Advisor | 14.2763 | 21915657 | 21915657 | 2023-09-15 | |
ACME, LLC | Venture Capital | 9.928 | 15240546 | 0 | 2023-06-30 | LOW |
Koch Industries, Inc. | Investment Advisor | 8.3892 | 12878392 | -299991 | 2023-06-30 | MED |
Khattak (Ayub K) | Individual Investor | 7.1081 | 10911670 | -41002 | 2023-09-25 | LOW |
Oakmont Corporation | Hedge Fund | 6.2506 | 9595348 | 0 | 2023-10-06 | LOW |
Decheng Capital Management III (Cayman) LLC | Investment Advisor | 5.8503 | 8980909 | 0 | 2023-06-30 | LOW |
Madrone Advisors, LLC | Investment Advisor | 4.6111 | 7078566 | 0 | 2023-06-30 | LOW |
Johnson & Johnson Innovation-JJDC, Inc. | Venture Capital | 3.6146 | 5548864 | 0 | 2023-06-30 | LOW |
Jabodon Pt. Co. | Investment Advisor | 2.5935 | 3981258 | 0 | 2023-09-30 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.5303 | 3884285 | -461854 | 2023-06-30 | LOW |
Temasek Holdings Pte. Ltd. | Sovereign Wealth Fund | 2.0357 | 3125000 | 0 | 2023-06-30 | LOW |
Sever (Clinton) | Individual Investor | 1.9538 | 2999291 | -41667 | 2023-09-25 | LOW |
Capital World Investors | Investment Advisor | 1.14 | 1750000 | -625000 | 2022-03-31 | LOW |
Achar (Christopher K) | Individual Investor | 1.0564 | 1621651 | -191894 | 2023-09-25 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.8737 | 1341246 | -4400032 | 2023-06-30 | LOW |
Verition Fund Management LLC | Hedge Fund | 0.6514 | 1000000 | 1000000 | 2023-06-30 | HIGH |
Bleichroeder LP | Investment Advisor | 0.6514 | 1000000 | 0 | 2023-06-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.6451 | 990275 | -985614 | 2023-06-30 | LOW |
Jacobs Levy Equity Management, Inc. | Investment Advisor/Hedge Fund | 0.576 | 884272 | 639501 | 2023-06-30 | MED |
Palsis (Erica) | Individual Investor | 0.5275 | 809712 | -6272 | 2023-09-05 | LOW |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Cue Health Inc. Company profile
About Cue Health Inc
Cue Health Inc. is a health technology company. The Company has developed a platform, the Cue Integrated Care Platform, with a focus on user experience, convenience, and accuracy. The Cue Integrated Care Platform consists of hardware and software components: Cue Health Monitoring System includes Cue Reader, made up of a portable, durable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand a sample collection wand; Cue Data and Innovation Layer, with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, including its consumer-friendly Cue Health App and its Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, which allow for integrations with third-party applications and sensors. Its product offering is Cue COVID-19 Test. Its COVID-19 test, consist Cue Reader and COVID-19 Test Kit (Cue COVID-19 Cartridge and Cue Wand), is designed to detect SARS-CoV-2, the virus that causes COVID-19.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Cue Health Inc revenues increased from $9.7M to $425.6M. Net income totaled $52.2M vs. loss of $27.8M. Revenues reflect Software segment increase from $4.7M to $223.7M. Net Income reflects Software segment income totaling $87.4M vs. loss of $8.5M. Basic Earnings per Share excluding Extraordinary Items increased from -$0.19 to $0.36.
Industry: | Software (NEC) |
4980 Carroll Canyon Road
Suite 100
SAN DIEGO
CALIFORNIA 92121
US
Income Statement
- Annual
- Quarterly
News

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
12:39, 30 November 2023
Euro Zone CPI expected to continue dropping; economists warn about cutting too soon
EZ PI expected to drop further but speed of decline
08:16, 29 November 2023
A weaker Dollar drives gold higher
Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.
13:49, 28 November 2023
Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain
US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.
13:20, 28 November 2023
RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023
The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.
13:04, 28 November 2023
Crude prices slide on OPEC+ uncertainty
Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.
12:55, 28 November 2023
UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?
UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.
10:48, 21 November 2023People also watch
Still looking for a broker you can trust?
Join the 570.000+ traders worldwide that chose to trade with Capital.com